![NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders](https://johnsonfrancis.org/professional/wp-content/uploads/2022/08/NODE-clinical-trials-of-Etripamil-nasal-spray-for-PSVT.jpg)
NODE clinical trials of Etripamil nasal spray for PSVT – All About Cardiovascular System and Disorders
![Abstract 11430: Etripamil Nasal Spray Reduces Heart Rate in Patients with Paroxysmal Supraventricular Tachycardia Prior to Conversion to Sinus Rhythm | Circulation Abstract 11430: Etripamil Nasal Spray Reduces Heart Rate in Patients with Paroxysmal Supraventricular Tachycardia Prior to Conversion to Sinus Rhythm | Circulation](https://www.ahajournals.org/cms/asset/3e3bcc11-e340-4f96-b7f9-f1c22d1edf5d/g11430.jpg)
Abstract 11430: Etripamil Nasal Spray Reduces Heart Rate in Patients with Paroxysmal Supraventricular Tachycardia Prior to Conversion to Sinus Rhythm | Circulation
![Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia – touchCARDIO Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia – touchCARDIO](https://www.touchcardio.com/wp-content/uploads/sites/4/2021/07/Gupta-Table-1.png)
Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia – touchCARDIO
![ACCP EMED PRN on X: "Etripamil nasal spray is superior to placebo for rapid conversion of sinus rhythm 🫀 and well tolerated in patients with sustained PSVT https://t.co/fril4rYiPi" / X ACCP EMED PRN on X: "Etripamil nasal spray is superior to placebo for rapid conversion of sinus rhythm 🫀 and well tolerated in patients with sustained PSVT https://t.co/fril4rYiPi" / X](https://pbs.twimg.com/media/GD-n_Y4XIAA-T9b.jpg:large)
ACCP EMED PRN on X: "Etripamil nasal spray is superior to placebo for rapid conversion of sinus rhythm 🫀 and well tolerated in patients with sustained PSVT https://t.co/fril4rYiPi" / X
![Snortable drug that mends irregular heartbeat within 30 minutes could be rolled out next year | Daily Mail Online Snortable drug that mends irregular heartbeat within 30 minutes could be rolled out next year | Daily Mail Online](https://i.dailymail.co.uk/1s/2022/10/17/16/63558381-11324279-image-a-3_1666022034411.jpg)
Snortable drug that mends irregular heartbeat within 30 minutes could be rolled out next year | Daily Mail Online
![The Efficacy and Safety of Etripamil Nasal Spray for Acute Paroxysmal Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | American Journal of Cardiovascular Drugs The Efficacy and Safety of Etripamil Nasal Spray for Acute Paroxysmal Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | American Journal of Cardiovascular Drugs](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40256-023-00592-7/MediaObjects/40256_2023_592_Fig4_HTML.png)
The Efficacy and Safety of Etripamil Nasal Spray for Acute Paroxysmal Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | American Journal of Cardiovascular Drugs
The EKG Guy - 𝐍𝐄𝐖 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡: Etripamil nasal spray -- a potential convenient, safe, and effective means for patients to terminate paroxysmal SVT. -- The EKG Guy and colleagues EKG videos: https://www.youtube.com/c/theekgguy?sub_confirmation=1
![First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology](https://www.ahajournals.org/cms/asset/090314cd-5ab6-44b8-8580-19dcbe838c49/circep.122.010915.fig01.jpg)
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301) | Circulation: Arrhythmia and Electrophysiology
![PDF] Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. | Semantic Scholar PDF] Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. | Semantic Scholar](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/5cf7d780af6a37fdcd5c9dead4add64196cbe528/4-Figure1-1.png)